Yellow Fever and MS: A Trade-Off?

Are you about to travel to Africa? Your doctor might tell you to get some vaccinations. If you have multiple sclerosis (MS), you may want to think twice before getting the yellow fever vaccine.

FDA Declines Diabetes Drug

Even if sceintist believe a drug is a breakthrough in the treatment of a disease, it is not a shoe-in for FDA approval. Dangerous side effects can keep a drug off the market.

First Stem Cell Stroke Trial Begins

Time is of essence when a stroke happens. Most traditional stroke treatments are given shortly after onset. A new clinical trial is testing the effectiveness of a stem cell therapy that could be given 19 days later.

Improving Post-Cardiac Arrest Outcome

Following cardiac arrest, one patient may recover quickly while another struggles with lingering symptoms. But interestingly enough, classifying patients might help improve patient outcomes — regardless of illness severity.

FDA Reminder: Do Not Give Infants Cough and Cold Products Designed for Older Children

In January 2008, manufacturers voluntarily removed over-the-counter (OTC) infant (less than 2 years of age) cough and cold products from the market due to safety concerns. Later in fall of 2008, manufacturers also voluntarily relabeled these cough and cold products to state: “do not use in children under 4 years of age.” However, there are concerns that many parents may be giving cough and cold products that remain on the market - those designed for older children - to their infants. FDA reminds all caregivers never to give a child under two years of age any kind of cough and cold p...

Underage Drinking Damages the Brain

It’s not a joke when experts say binge drinking is dangerous. Binge drinking is a serious problem for adults, so it only makes sense that the problem is even worse for teenagers.

FDA Approves Cardiac Drug Ticagrelor

After a lengthy regulation process, the U.S. Food and Drug Administration has approved blood-thinning drug Brilinta (ticagrelor) to treat patients with acute coronary syndromes.

Stroke Care Awareness Urged

Strokes can strike anyone one regardless of income, race, gender or insurance coverage. That doesn't necessarily mean that all groups are receiving adequate stroke care.

FDA Approves Drug for Acute Coronary Syndromes

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta ( ticagrelor ) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

FDA Drug Safety Communication: Bisphosphonates and Esophageal Cancer

The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer).